Why COVID-19 Causes Loss of Taste and Smell
COVID-19 causes loss of smell and taste primarily through infection and inflammation of non-neuronal support cells in the olfactory epithelium, rather than by directly infecting smell neurons themselves. This leads to tissue damage, inflammatory responses, and downregulation of odorant receptors that collectively impair smell function 1.
The Mechanism of Olfactory Dysfunction
The pathophysiology involves several interconnected processes:
Primary Site of Infection
SARS-CoV-2 targets the olfactory neuroepithelium (the smell-sensing tissue in the nose), but contrary to initial assumptions, the virus rarely infects the actual olfactory sensory neurons 2. Instead, it infects:
- Support cells (sustentacular cells) in the olfactory epithelium
- Immune cells that infiltrate the tissue
- Other non-neuronal cell types 3
Downstream Effects
Once these support cells are infected, several mechanisms impair smell function 2:
- Tissue damage from viral replication in support cells
- Local inflammatory responses with immune cell infiltration into the olfactory epithelium 3
- Systemic circulation of inflammatory cytokines that affect olfactory function
- Downregulation of odorant receptor genes in olfactory sensory neurons, even though the neurons themselves aren't infected 4
- Loss of cilia on olfactory sensory neurons, similar to other viral causes of smell loss 1
The "Taste" Component
The loss of taste is actually a misnomer in most cases 1. What patients perceive as taste loss is predominantly loss of flavor perception due to retronasal olfaction (smell contributing to flavor while eating), rather than true loss of taste sensation. The virus can infect taste cells in fungiform papillae, but the clinical impact appears less significant than olfactory dysfunction 4.
Clinical Implications
Viral Persistence
A critical finding is that SARS-CoV-2 can persist in the olfactory epithelium even after respiratory symptoms resolve 3. This viral persistence, combined with ongoing inflammation, explains why some patients experience prolonged anosmia lasting weeks to months beyond their acute illness.
Recovery Timeline
Recovery patterns show 1:
- Short-term recovery occurs in 44-73% of patients
- Mean time to improvement is approximately 7.2 days
- Complete resolution may take several weeks
- Some patients develop persistent post-viral olfactory loss requiring longer-term management
Key Distinguishing Features
Anosmia in COVID-19 differs from other respiratory infections 5:
- 10.2-fold higher prevalence compared to other respiratory infections
- Often occurs as an early or isolated symptom (26.6% report it as the initial symptom) 1
- Can occur without nasal congestion, unlike typical viral upper respiratory infections 1
Important Clinical Caveats
The debate continues regarding the relative contributions of olfactory cleft edema, architectural deformity of the neuroepithelium, and potential neuroinvasion 1. However, current evidence strongly favors indirect mechanisms through support cell infection and inflammation rather than direct neuronal infection 2.
The TMPRSS2 receptor plays a key role in viral entry by cleaving the spike protein, and genetic variations in this receptor may influence susceptibility to anosmia 6. Notably, different variants show varying dependence on this pathway, with Delta strains more TMPRSS2-dependent than Omicron strains.